Prevalence and clinical associations of myositis antibodies in a large cohort of interstitial lung diseases
<h4>Background</h4> Serologic testing for autoantibodies is recommended in interstitial lung diseases (ILDs), as connective tissue diseases (CTDs) are an important secondary cause. Myositis antibodies are associated with CTD-ILD, but clinical associations with other ILDs are unclear. In...
Main Authors: | Sofia A. Moll, Mark G. J. P. Platenburg, Anouk C. M. Platteel, Adriane D. M. Vorselaars, Montse Janssen Bonàs, Raisa Kraaijvanger, Claudia Roodenburg-Benschop, Bob Meek, Coline H. M. van Moorsel, Jan C. Grutters |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632801/?tool=EBI |
Similar Items
-
Prevalence and clinical associations of myositis antibodies in a large cohort of interstitial lung diseases.
by: Sofia A Moll, et al.
Published: (2022-01-01) -
Decreased serpin C1 in extracellular vesicles predicts response to methotrexate treatment in patients with pulmonary sarcoidosis
by: Raisa Kraaijvanger, et al.
Published: (2024-04-01) -
Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study
by: Vivienne Kahlmann, et al.
Published: (2020-10-01) -
Bilateral Vocal Cord Carcinoma in a Sarcoidosis Patient during Infliximab Therapy
by: Adriane D. M. Vorselaars, et al.
Published: (2013-01-01) -
Elevated Serum Amyloid a Levels Are not Specific for Sarcoidosis but Associate with a Fibrotic Pulmonary Phenotype
by: Els Beijer, et al.
Published: (2021-03-01)